These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8920815)
21. Protective immunity induced by a Yersinia enterocolitica serovar 0:8 cellular extract. Di Genaro MS; Escudero ME; Maccioni M; Stefanini de Guzmán AM Biocell; 1996 Dec; 20(3):235-41. PubMed ID: 9031590 [TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies and characterization of epitopes of smooth Brucella lipopolysaccharides. Greiser-Wilke I; Moennig V Ann Inst Pasteur Microbiol; 1987; 138(5):549-60. PubMed ID: 2449902 [TBL] [Abstract][Full Text] [Related]
23. Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity. Schmidt A; Schaffelhofer S; Müller K; Röllinghoff M; Beuscher HU Microb Pathog; 1999 Apr; 26(4):221-33. PubMed ID: 10089162 [TBL] [Abstract][Full Text] [Related]
24. Intranasal immunization with Yersinia enterocolitica O:8 cellular extract protects against local challenge infection. Di Genaro MS; Escudero ME; Muñoz E; Aguilera C; Scardapane L; de Guzmán AM Microbiol Immunol; 1998; 42(11):781-8. PubMed ID: 9886151 [TBL] [Abstract][Full Text] [Related]
25. The lipopolysaccharide outer core of Yersinia enterocolitica serotype O:3 is required for virulence and plays a role in outer membrane integrity. Skurnik M; Venho R; Bengoechea JA; Moriyón I Mol Microbiol; 1999 Mar; 31(5):1443-62. PubMed ID: 10200964 [TBL] [Abstract][Full Text] [Related]
26. Antibody inhibition of HeLa cell invasion by Yersinia enterocolitica. Schiemann DA; Nelson CM Can J Microbiol; 1988 Jan; 34(1):52-7. PubMed ID: 3132317 [TBL] [Abstract][Full Text] [Related]
27. Functional, molecular and structural characterisation of five anti-Brucella LPS mAb. Laurent TC; Mertens P; Dierick JF; Letesson JJ; Lambert C; De Bolle X Mol Immunol; 2004 Mar; 40(17):1237-47. PubMed ID: 15128040 [TBL] [Abstract][Full Text] [Related]
28. Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. Phalipon A; Kaufmann M; Michetti P; Cavaillon JM; Huerre M; Sansonetti P; Kraehenbuhl JP J Exp Med; 1995 Sep; 182(3):769-78. PubMed ID: 7544397 [TBL] [Abstract][Full Text] [Related]
29. A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice. Singh AK; Kingston JJ; Murali HS; Batra HV Vaccine; 2014 Mar; 32(11):1233-9. PubMed ID: 24486353 [TBL] [Abstract][Full Text] [Related]
30. Characterization of anti-ECA antibodies in rabbit antiserum against rough Yersinia enterocolitica O:3. Rabsztyn K; Kasperkiewicz K; Duda KA; Li CM; Lukasik M; Radziejewska-Lebrecht J; Skurnik M Biochemistry (Mosc); 2011 Jul; 76(7):832-9. PubMed ID: 21999545 [TBL] [Abstract][Full Text] [Related]
31. Enterobacterial common antigen and O-specific polysaccharide coexist in the lipopolysaccharide of Yersinia enterocolitica serotype O:3. Muszyński A; Rabsztyn K; Knapska K; Duda KA; Duda-Grychtoł K; Kasperkiewicz K; Radziejewska-Lebrecht J; Holst O; Skurnik M Microbiology (Reading); 2013 Aug; 159(Pt 8):1782-1793. PubMed ID: 23782803 [TBL] [Abstract][Full Text] [Related]
32. Characterization of O-polysaccharide specific monoclonal antibodies derived from mice infected with the rough Brucella melitensis strain B115. Cloeckaert A; Zygmunt MS; Dubray G; Limet JN J Gen Microbiol; 1993 Jul; 139(7):1551-6. PubMed ID: 7690392 [TBL] [Abstract][Full Text] [Related]
33. Influence of surface modulations by enzymes and monoclonal antibodies on alternative complement pathway activation by Yersinia enterocolitica. Wachter E; Brade V Infect Immun; 1989 Jul; 57(7):1984-9. PubMed ID: 2731980 [TBL] [Abstract][Full Text] [Related]
34. Immunomodulation in mice by experimental infection with Yersinia enterocolitica. Ruiz-Bravo A; Jimenez-Valera M; Alvarez de Cienfuegos G; Ruiz C; Kouwatli K; Ramos-Cormenzana A Microbiol Immunol; 1985; 29(11):1089-97. PubMed ID: 4094572 [TBL] [Abstract][Full Text] [Related]
35. The serological response of cattle immunized with Yersinia enterocolitica O:9 or O:16 to Yersinia and Brucella abortus antigens in enzyme immunoassays. Nielsen K Vet Immunol Immunopathol; 1990 Apr; 24(4):373-82. PubMed ID: 2111058 [TBL] [Abstract][Full Text] [Related]
36. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens]. Rastawicki W Med Dosw Mikrobiol; 2008; 60(1):27-37. PubMed ID: 18634341 [TBL] [Abstract][Full Text] [Related]
37. Specificity and function of monoclonal antibodies reactive with discrete structural elements of bacterial lipopolysaccharide. Pollack M; Oishi K; Chia J; Evans M; Guelde G; Koles N Adv Exp Med Biol; 1990; 256():331-40. PubMed ID: 1691578 [TBL] [Abstract][Full Text] [Related]
38. Lipopolysaccharide O side chain of Yersinia enterocolitica O:3 is an essential virulence factor in an orally infected murine model. al-Hendy A; Toivanen P; Skurnik M Infect Immun; 1992 Mar; 60(3):870-5. PubMed ID: 1311707 [TBL] [Abstract][Full Text] [Related]
39. [Structure of the O-specific polysaccharide of the Yersinia enterocolitica serovar O:4.32 lipopolysaccharide. Serologic relations of lipopolysaccharides of Y. enterocolitica O:4.32 and Y. intermedia O:4.33]. Zubkov VA; Gorshkova RP; Burtseva TI; Isakov VV; Ovodov IuS Bioorg Khim; 1989 Feb; 15(2):187-91. PubMed ID: 2472796 [TBL] [Abstract][Full Text] [Related]